Transcriptional Regulation by MECP2

Pathway network for the Transcriptional Regulation by MECP2 SuperPath

Sources:

Reactome

Pathways in the Transcriptional Regulation by MECP2 SuperPath

#	Name	Source	Genes
1	Transcriptional Regulation by MECP2	Reactome	AGO1 AGO2 AGO3 AGO4 AURKB BDNF CALM1 CALM2 CALM3 CAMK2A CAMK2B CAMK2D CAMK2G CAMK4 CREB1 CRH DGCR8 DLL1 FKBP5 FOXG1 GAD1 GAD2 GAMT GPRIN1 GPS2 GRIA2 GRIN2A GRIN2B HDAC1 HDAC2 HDAC3 HIPK2 HTT IRAK1 LBR MECP2 MEF2C MET MOBP MOV10 NCOR1 NCOR2 OPRK1 OPRM1 PPARG PRKACA PTEN PTPN1 PTPN4 PVALB RBFOX1 SGK1 SIN3A SLC2A3 SOX2 SST TBL1X TBL1XR1 TNRC6A TNRC6B TNRC6C TRPC3 (see all 62) (see less)
2	Regulation of MECP2 expression and activity	Reactome	AGO1 AGO2 AGO3 AGO4 AURKB CALM1 CALM2 CALM3 CAMK2A CAMK2B CAMK2D CAMK2G CAMK4 CREB1 FOXG1 GPS2 HDAC1 HDAC2 HDAC3 HIPK2 HTT LBR MECP2 MOV10 NCOR1 NCOR2 PRKACA SIN3A TBL1X TBL1XR1 TNRC6A TNRC6B TNRC6C (see all 33) (see less)
3	MECP2 regulates neuronal receptors and channels	Reactome	CREB1 FKBP5 GPRIN1 GRIA2 GRIN2A GRIN2B HDAC1 HDAC2 MECP2 MET OPRK1 OPRM1 PTPN1 PTPN4 SIN3A SLC2A3 TRPC3 (see all 17) (see less)
4	Regulation of PTEN mRNA translation	Reactome	AGO1 AGO2 AGO3 AGO4 MOV10 PTEN TNRC6A TNRC6B TNRC6C (see all 9) (see less)
5	MECP2 regulates transcription of neuronal ligands	Reactome	BDNF CREB1 CRH DLL1 HDAC1 MECP2 SIN3A SST (see all 8) (see less)
6	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	Reactome	AGO1 AGO2 AGO3 AGO4 MOV10 TNRC6A TNRC6B TNRC6C (see all 8) (see less)
7	Post-transcriptional silencing by small RNAs	Reactome	AGO1 AGO2 AGO3 AGO4 TNRC6A TNRC6B TNRC6C (see all 7) (see less)
8	MECP2 regulates transcription factors	Reactome	CREB1 MECP2 MEF2C PPARG RBFOX1
9	Loss of MECP2 binding ability to 5mC-DNA	Reactome	HDAC1 MECP2 SIN3A
10	MECP2 regulates transcription of genes involved in GABA signaling	Reactome	GAD1 GAD2 MECP2
11	Loss of MECP2 binding ability to 5hmC-DNA	Reactome	MECP2

Gene overlap in member pathways for Transcriptional Regulation by MECP2 SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	MECP2	Methyl-CpG Binding Protein 2	Protein Coding	8
2	CREB1	CAMP Responsive Element Binding Protein 1	Protein Coding	5
3	AGO3	Argonaute RISC Catalytic Component 3	Protein Coding	5
4	AGO4	Argonaute RISC Component 4	Protein Coding	5
5	TNRC6B	Trinucleotide Repeat Containing Adaptor 6B	Protein Coding	5
6	SIN3A	SIN3 Transcription Regulator Family Member A	Protein Coding	5
7	AGO1	Argonaute RISC Component 1	Protein Coding	5
8	AGO2	Argonaute RISC Catalytic Component 2	Protein Coding	5
9	TNRC6A	Trinucleotide Repeat Containing Adaptor 6A	Protein Coding	5
10	HDAC1	Histone Deacetylase 1	Protein Coding	5
11	TNRC6C	Trinucleotide Repeat Containing Adaptor 6C	Protein Coding	5
12	MOV10	Mov10 RNA Helicase	Protein Coding	4
13	HDAC2	Histone Deacetylase 2	Protein Coding	3
14	GPRIN1	G Protein Regulated Inducer Of Neurite Outgrowth 1	Protein Coding	2
15	CRH	Corticotropin Releasing Hormone	Protein Coding	2
16	FKBP5	FKBP Prolyl Isomerase 5	Protein Coding	2
17	FOXG1	Forkhead Box G1	Protein Coding	2
18	GAD1	Glutamate Decarboxylase 1	Protein Coding	2
19	GAD2	Glutamate Decarboxylase 2	Protein Coding	2
20	DLL1	Delta Like Canonical Notch Ligand 1	Protein Coding	2
21	GPS2	G Protein Pathway Suppressor 2	Protein Coding	2
22	GRIA2	Glutamate Ionotropic Receptor AMPA Type Subunit 2	Protein Coding	2
23	HIPK2	Homeodomain Interacting Protein Kinase 2	Protein Coding	2
24	GRIN2A	Glutamate Ionotropic Receptor NMDA Type Subunit 2A	Protein Coding	2
25	GRIN2B	Glutamate Ionotropic Receptor NMDA Type Subunit 2B	Protein Coding	2
26	HTT	Huntingtin	Protein Coding	2
27	LBR	Lamin B Receptor	Protein Coding	2
28	MEF2C	Myocyte Enhancer Factor 2C	Protein Coding	2
29	MET	MET Proto-Oncogene, Receptor Tyrosine Kinase	Protein Coding	2
30	OPRK1	Opioid Receptor Kappa 1	Protein Coding	2
31	OPRM1	Opioid Receptor Mu 1	Protein Coding	2
32	PPARG	Peroxisome Proliferator Activated Receptor Gamma	Protein Coding	2
33	RBFOX1	RNA Binding Fox-1 Homolog 1	Protein Coding	2
34	PRKACA	Protein Kinase CAMP-Activated Catalytic Subunit Alpha	Protein Coding	2
35	PTEN	Phosphatase And Tensin Homolog	Protein Coding	2
36	PTPN1	Protein Tyrosine Phosphatase Non-Receptor Type 1	Protein Coding	2
37	PTPN4	Protein Tyrosine Phosphatase Non-Receptor Type 4	Protein Coding	2
38	BDNF	Brain Derived Neurotrophic Factor	Protein Coding	2
39	SLC2A3	Solute Carrier Family 2 Member 3	Protein Coding	2
40	SST	Somatostatin	Protein Coding	2
41	TBL1X	Transducin Beta Like 1 X-Linked	Protein Coding	2
42	TRPC3	Transient Receptor Potential Cation Channel Subfamily C Member 3	Protein Coding	2
43	TBL1XR1	TBL1X/Y Related 1	Protein Coding	2
44	CALM1	Calmodulin 1	Protein Coding	2
45	CALM2	Calmodulin 2	Protein Coding	2
46	CALM3	Calmodulin 3	Protein Coding	2
47	CAMK4	Calcium/Calmodulin Dependent Protein Kinase IV	Protein Coding	2
48	CAMK2A	Calcium/Calmodulin Dependent Protein Kinase II Alpha	Protein Coding	2
49	CAMK2B	Calcium/Calmodulin Dependent Protein Kinase II Beta	Protein Coding	2
50	CAMK2D	Calcium/Calmodulin Dependent Protein Kinase II Delta	Protein Coding	2
51	CAMK2G	Calcium/Calmodulin Dependent Protein Kinase II Gamma	Protein Coding	2
52	HDAC3	Histone Deacetylase 3	Protein Coding	2
53	AURKB	Aurora Kinase B	Protein Coding	2
54	NCOR1	Nuclear Receptor Corepressor 1	Protein Coding	2
55	NCOR2	Nuclear Receptor Corepressor 2	Protein Coding	2
56	GAMT	Guanidinoacetate N-Methyltransferase	Protein Coding	1
57	IRAK1	Interleukin 1 Receptor Associated Kinase 1	Protein Coding	1
58	MOBP	Myelin Associated Oligodendrocyte Basic Protein	Protein Coding	1
59	DGCR8	DGCR8 Microprocessor Complex Subunit	Protein Coding	1
60	PVALB	Parvalbumin	Protein Coding	1
61	SGK1	Serum/Glucocorticoid Regulated Kinase 1	Protein Coding	1
62	SOX2	SRY-Box Transcription Factor 2	Protein Coding	1

Disorders associated with Transcriptional Regulation by MECP2 SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Rett syndrome	Direct
2	Catecholaminergic polymorphic ventricular tachycardia	Enrichment	CALM1, CALM2, CALM3	6.14
3	Epilepsy	Enrichment	GRIN2A, GRIN2B, MECP2	4.80
4	Complex neurodevelopmental disorder	Enrichment	AGO1, AGO2, TNRC6B	4.60
5	Long qt syndrome 1	Enrichment	CALM1, CALM2, CALM3	4.29
6	Autosomal dominant non-syndromic intellectual disability	Enrichment	CAMK2A, CAMK2B, DLL1, GRIN2B	4.11
7	Congenital nervous system abnormality	Enrichment	CAMK2B, FOXG1, GAMT, MECP2, PTEN	3.92
8	Nervous system disease	Enrichment	CAMK2B, FOXG1, GAMT, MECP2, PTEN	3.92
9	Huntington disease	Enrichment	HTT, SLC2A3	3.91
10	Autism spectrum disorder	Enrichment	GRIN2B, MECP2, MEF2C, PTEN, TNRC6B	3.86
11	Rett syndrome, congenital variant	Enrichment	FOXG1, MECP2	3.80
12	Facial hypertrichosis	Enrichment	MECP2	3.66
13	Intellectual developmental disorder, x-linked, syndromic, lubs type	Enrichment	MECP2	3.66
14	Autism x-linked 3	Enrichment	MECP2	3.66
15	Developmental and epileptic encephalopathy 89	Enrichment	GAD1	3.66
16	Syndromic x-linked intellectual disability lubs type	Enrichment	MECP2	3.66
17	Autism	Enrichment	MECP2, RBFOX1	3.56
18	Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language	Enrichment	MEF2C	3.43
19	Pparg-associated congenital generalized lipodystrophy	Enrichment	PPARG	3.43
20	5q14.3 microdeletion syndrome	Enrichment	MEF2C	3.43
21	Complete atrioventricular septal defect without ventricular hypoplasia	Enrichment	MEF2C	3.43
22	Mef2c-related disorder	Enrichment	MEF2C	3.43
23	Colorectal cancer	Enrichment	PPARG, RBFOX1	3.40
24	Stereotypic movement disorder	Enrichment	FOXG1, MECP2	3.36
25	Encephalopathy, neonatal severe, due to mecp2 mutations	Enrichment	MECP2	3.35
26	Intellectual developmental disorder, x-linked, syndromic 13	Enrichment	MECP2	3.35
27	X-linked intellectual disability-psychosis-macroorchidism syndrome	Enrichment	MECP2	3.35
28	Progressive bulbar palsy	Enrichment	MECP2	3.35
29	Bruxism	Enrichment	MECP2	3.35
30	Global developmental delay with speech and behavioral abnormalities	Enrichment	TNRC6B	3.29
31	Epilepsy, familial adult myoclonic, 6	Enrichment	TNRC6A	3.29
32	Chromosome 15q24 deletion syndrome	Enrichment	SIN3A	3.23
33	Laryngomalacia	Enrichment	MECP2	3.18
34	Vacterl association with hydrocephalus	Enrichment	PTEN	3.18
35	Papillary tumor of the pineal region	Enrichment	PTEN	3.18
36	Glioma susceptibility 2	Enrichment	PTEN	3.18
37	Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome	Enrichment	PTEN	3.18
38	Carotid intimal medial thickness 1	Enrichment	PPARG	3.13
39	Histiocytoma, angiomatoid fibrous	Enrichment	CREB1	3.13
40	Familial partial lipodystrophy	Enrichment	PPARG	3.13
41	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities	Enrichment	GAD1	3.05
42	Spastic quadriplegic cerebral palsy	Enrichment	GAD1	3.05
43	Sick sinus syndrome	Enrichment	MECP2	3.05
44	Premature ovarian failure 3	Enrichment	AGO2	2.99
45	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures	Enrichment	AGO1	2.99
46	Melanoma of soft tissue	Enrichment	CREB1	2.96
47	Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures	Enrichment	DLL1	2.93
48	Witteveen-kolk syndrome	Enrichment	SIN3A	2.93
49	Epilepsy, focal, with speech disorder and with or without impaired intellectual development	Enrichment	GRIN2A	2.90
50	Developmental and epileptic encephalopathy 27	Enrichment	GRIN2B	2.90
51	Spinocerebellar ataxia 41	Enrichment	TRPC3	2.90
52	Osteofibrous dysplasia	Enrichment	MET	2.90
53	Deafness, autosomal recessive 97	Enrichment	MET	2.90
54	Autism 9	Enrichment	MET	2.90
55	Intellectual developmental disorder, autosomal dominant 6, with or without seizures	Enrichment	GRIN2B	2.90
56	Neurodevelopmental disorder with language impairment and behavioral abnormalities	Enrichment	GRIA2	2.90
57	Arthrogryposis, distal, type 11	Enrichment	MET	2.90
58	Grin2b-related neurodevelopmental disorder	Enrichment	GRIN2B	2.90
59	Landau-kleffner syndrome	Enrichment	GRIN2A	2.90
60	Gria2-related neurodevelopmental disorder	Enrichment	GRIA2	2.90
61	Early-onset epileptic encephalopathy and intellectual disability due to grin2a mutation	Enrichment	GRIN2A	2.90
62	Grin2a-related disorders	Enrichment	GRIN2A	2.90
63	Angelman syndrome	Enrichment	MECP2	2.88
64	Vacterl with hydrocephalus	Enrichment	PTEN	2.88
65	Juvenile polyposis of infancy	Enrichment	PTEN	2.88
66	Lipodystrophy, familial partial, type 3	Enrichment	PPARG	2.83
67	Leptin deficiency or dysfunction	Enrichment	PPARG	2.83
68	Congenital generalized lipodystrophy	Enrichment	PPARG	2.83
69	Lessel-kreienkamp syndrome	Enrichment	AGO2	2.81
70	Focal epilepsy	Enrichment	MECP2	2.81
71	Laryngeal squamous cell carcinoma	Enrichment	PTEN	2.70
72	Hypothyroidism, congenital, nongoitrous, 8	Enrichment	TBL1X	2.61
73	Greenberg dysplasia	Enrichment	LBR	2.61
74	Pelger-huet anomaly	Enrichment	LBR	2.61
75	Rhizomelic skeletal dysplasia with or without pelger-huet anomaly	Enrichment	LBR	2.61
76	Intellectual developmental disorder, autosomal recessive 63	Enrichment	CAMK2A	2.61
77	Intellectual developmental disorder, autosomal dominant 54	Enrichment	CAMK2B	2.61
78	Long qt syndrome 16	Enrichment	CALM3	2.61
79	Pigmented nodular adrenocortical disease, primary, 4	Enrichment	PRKACA	2.61
80	Reynolds syndrome	Enrichment	LBR	2.61
81	Cardioacrofacial dysplasia 1	Enrichment	PRKACA	2.61
82	Lopes-maciel-rodan syndrome	Enrichment	HTT	2.61
83	Intellectual developmental disorder, autosomal dominant 53	Enrichment	CAMK2A	2.61
84	Intellectual developmental disorder, autosomal dominant 59	Enrichment	CAMK2G	2.61
85	Long qt syndrome 15	Enrichment	CALM2	2.61
86	Foxg1 syndrome due to intragenic alteration	Enrichment	FOXG1	2.61
87	Foxg1 syndrome due to 14q12 microdeletion	Enrichment	FOXG1	2.61
88	Juvenile huntington disease	Enrichment	HTT	2.61
89	Childhood hepatocellular carcinoma	Enrichment	MET	2.60
90	Intellectual developmental disorder, autosomal dominant 21	Enrichment	GRIN2A	2.60
91	Papillary renal cell carcinoma	Enrichment	MET	2.60
92	Rolandic epilepsy-speech dyspraxia syndrome	Enrichment	GRIN2A	2.60
93	Epilepsy-aphasia spectrum	Enrichment	GRIN2A	2.60
94	Long qt syndrome	Enrichment	CALM1, CALM2	2.59
95	Glioma	Enrichment	PTEN	2.58
96	Dystonia	Enrichment	CAMK2B, MECP2	2.49
97	Macrocephaly/autism syndrome	Enrichment	PTEN	2.48
98	Hemangioma	Enrichment	PTEN	2.48
99	Acute megakaryocytic leukemia	Enrichment	PTEN	2.48
100	Hemimegalencephaly	Enrichment	PTEN	2.48
101	Diffuse large b-cell lymphoma	Enrichment	PTEN, TBL1XR1	2.48
102	Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome	Enrichment	BDNF	2.45
103	Renal cell carcinoma	Enrichment	MET	2.43
104	Cowden syndrome 1	Enrichment	PTEN	2.40
105	Autosomal dominant sleep-related hypermotor epilepsy	Enrichment	CRH	2.38
106	Thyroid cancer, nonmedullary, 2	Enrichment	PTEN	2.33
107	Squamous cell carcinoma, head and neck	Enrichment	PTEN	2.33
108	Follicular thyroid carcinoma	Enrichment	PTEN	2.33
109	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	TNRC6B	2.33
110	Attention deficit-hyperactivity disorder	Enrichment	MECP2	2.31
111	Ventricular tachycardia, catecholaminergic polymorphic, 4	Enrichment	CALM1	2.31
112	Long qt syndrome 14	Enrichment	CALM1	2.31
113	Fibrolamellar carcinoma	Enrichment	PRKACA	2.31
114	Astigmatism	Enrichment	GRIN2B	2.30
115	Congenital central hypoventilation syndrome	Enrichment	BDNF	2.28
116	Gliosarcoma	Enrichment	PPARG	2.23
117	Cowden syndrome	Enrichment	PTEN	2.22
118	Major depressive disorder	Enrichment	FKBP5	2.20
119	Sleep disorder	Enrichment	GRIN2B	2.20
120	Giant cell glioblastoma	Enrichment	PPARG	2.20
121	Melanoma	Enrichment	PTEN	2.18
122	Meningioma, familial	Enrichment	PTEN	2.14
123	Uterine corpus cancer	Enrichment	PTEN	2.14
124	Pierpont syndrome	Enrichment	TBL1XR1	2.14
125	Intellectual developmental disorder, autosomal dominant 41	Enrichment	TBL1XR1	2.14
126	Meningioma	Enrichment	PTEN	2.10
127	Non-syndromic x-linked intellectual disability	Enrichment	MECP2	2.10
128	Systemic lupus erythematosus	Enrichment	MECP2	2.07
129	Renal cell carcinoma, papillary, 1	Enrichment	MET	2.06
130	Septopreoptic holoprosencephaly	Enrichment	DLL1	2.05
131	Midline interhemispheric variant of holoprosencephaly	Enrichment	DLL1	2.05
132	Cerebral creatine deficiency syndrome 2	Enrichment	GAMT	2.04
133	Cerebral creatine deficiency syndrome	Enrichment	GAMT	2.04
134	Creatine deficiency disorders	Enrichment	GAMT	2.04
135	Microform holoprosencephaly	Enrichment	DLL1	2.03
136	Lobar holoprosencephaly	Enrichment	DLL1	2.03
137	Arthrogryposis, distal, type 1a	Enrichment	MET	2.00
138	Alobar holoprosencephaly	Enrichment	DLL1	2.00
139	Microcephaly	Enrichment	GRIN2B, MECP2	1.99
140	Rhabdomyosarcoma	Enrichment	PTEN	1.98
141	Semilobar holoprosencephaly	Enrichment	DLL1	1.98
142	Differentiated thyroid carcinoma	Enrichment	PPARG	1.97
143	Asthma	Enrichment	FKBP5	1.86
144	Endometrial cancer	Enrichment	PTEN	1.86
145	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy	Enrichment	CALM1	1.84
146	Benign epilepsy with centrotemporal spikes	Enrichment	RBFOX1	1.82
147	Type 2 diabetes mellitus	Enrichment	PPARG	1.81
148	Centralopathic epilepsy	Enrichment	RBFOX1	1.80
149	Microphthalmia, syndromic 3	Enrichment	SOX2	1.74
150	Pediatric systemic lupus erythematosus	Enrichment	IRAK1	1.74
151	Body mass index quantitative trait locus 11	Enrichment	PPARG	1.74
152	Renal cell carcinoma, nonpapillary	Enrichment	MET	1.73
153	Bladder cancer	Enrichment	PTEN	1.72
154	Prostate cancer	Enrichment	PTEN	1.72
155	Catecholaminergic polymorphic ventricular tachycardia 1	Enrichment	CALM1	1.71
156	Undetermined early-onset epileptic encephalopathy	Enrichment	RBFOX1	1.69
157	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	Enrichment	MEF2C	1.67
158	Schizophrenia	Enrichment	RBFOX1	1.67
159	Ellis-van creveld syndrome	Enrichment	PRKACA	1.66
160	Optic nerve disease	Enrichment	FOXG1	1.62
161	Craniosynostosis	Enrichment	GRIN2B	1.61
162	Myeloma, multiple	Enrichment	NCOR2, SGK1	1.57
163	Hepatocellular carcinoma	Enrichment	MET	1.56
164	Gastric cancer	Enrichment	PTEN	1.55
165	Hereditary breast carcinoma	Enrichment	PTEN	1.54
166	Scoliosis	Enrichment	GRIN2B	1.53
167	Acute promyelocytic leukemia	Enrichment	TBL1XR1	1.51
168	Nk-cell enteropathy	Enrichment	AURKB	1.51
169	Hereditary breast ovarian cancer syndrome	Enrichment	PTEN	1.44
170	Isolated congenital microcephaly	Enrichment	FOXG1	1.42
171	Lung cancer	Enrichment	MET	1.40
172	Sudden infant death syndrome	Enrichment	CALM2	1.39
173	Cerebral palsy	Enrichment	GRIN2B	1.32
174	Breast cancer	Enrichment	PTEN	1.31
175	Nanophthalmos	Enrichment	SOX2	1.31
176	Lissencephaly	Enrichment	FOXG1	1.30
177	Septooptic dysplasia	Enrichment	SOX2	1.27
178	West syndrome	Enrichment	GRIN2B	1.27
179	Jeune thoracic dystrophy	Enrichment	LBR	1.23
180	Strabismus	Enrichment	FOXG1	1.20
181	Ovarian cancer	Enrichment	PTEN	1.19
182	Asphyxiating thoracic dystrophy	Enrichment	LBR	1.18
183	Short-rib thoracic dysplasia 1 with or without polydactyly	Enrichment	LBR	1.11
184	Parkinson's disease	Enrichment	GAMT	1.08
185	Inherited cancer-predisposing syndrome	Enrichment	PTEN	1.07
186	Macs syndrome	Enrichment	SOX2	1.06
187	Microphthalmia	Enrichment	SOX2	1.02
188	Parkinson disease, late-onset	Enrichment	GAMT	0.98
189	Rare autosomal recessive non-syndromic sensorineural deafness type dfnb	Enrichment	MET	0.97

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Transcriptional Regulation by MECP2

Pathway Network for Transcriptional Regulation by MECP2

Pathway network for the Transcriptional Regulation by MECP2 SuperPath

Member Pathways for Transcriptional Regulation by MECP2

Pathways in the Transcriptional Regulation by MECP2 SuperPath

Gene overlap in member pathways for Transcriptional Regulation by MECP2 SuperPath

Associated Genes for Transcriptional Regulation by MECP2

Associated Disorders for Transcriptional Regulation by MECP2

Disorders associated with Transcriptional Regulation by MECP2 SuperPath

STRING Interaction Network for Transcriptional Regulation by MECP2

Sources for Transcriptional Regulation by MECP2